Fused pyrimidine compound or salt thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11236096
APP PUB NO 20200270261A1
SERIAL NO

16855332

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAIHO PHARMACEUTICAL CO LTD1-27 KANDANISHIKI-CHO CHIYODA-KU TOKYO 1018444 JAPAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fujita, Hidenori Tsukuba, JP 10 117
Kato, Masanori Tsukuba, JP 157 1153
Miyazaki, Isao Tsukuba, JP 28 611
Shimamura, Tadashi Tsukuba, JP 22 172

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 1, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 1, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 1, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00